Biopharmaceutical CMO and CRO Market Revenue 2024 to 2034
Biopharmaceutical CMO and CRO Market Revenue 2024 to 2034
The biopharmaceutical CMO & CRO market will grow from USD 38.56 Bn in 2024 to USD 72.38 Bn by 2034, at a 6.5% CAGR, supported by outsourcing trends, biologics production, and demand for cost-efficient drug development services.
Report ID: 10596
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 38.56 Bn
Forecast Year,
USD 72.38 Bn
CAGR, 2025 -
6.50%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Biopharmaceutical CMO and CRO Market Size Analysis
Biopharmaceutical CMO and CRO Market Size By Service 2024 to 2034 (USD )
| Service | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Contract Manufacturing | 21.59 | 23.04 | 24.58 | 26.22 | 27.97 | 29.85 | 31.84 | 33.97 | 36.25 | 38.67 | 41.26 |
| Contract Research | 16.97 | 18.03 | 19.16 | 20.36 | 21.63 | 22.98 | 24.42 | 25.95 | 27.57 | 29.29 | 31.12 |
Biopharmaceutical CMO and CRO Market Size By Source 2024 to 2034 (USD )
| Source | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mammalian | 24.68 | 26.28 | 27.99 | 29.81 | 31.75 | 33.82 | 36.02 | 38.36 | 40.85 | 43.51 | 46.34 |
| Non-mammalian | 13.88 | 14.78 | 15.74 | 16.77 | 17.85 | 19.01 | 20.25 | 21.56 | 22.96 | 24.45 | 26.04 |
Biopharmaceutical CMO and CRO Market Size By Product 2024 to 2034 (USD )
| Product | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MAbs | 12.34 | 13.10 | 13.92 | 14.78 | 15.70 | 16.67 | 17.71 | 18.80 | 19.97 | 21.21 | 22.52 |
| Vaccines | 9.25 | 9.89 | 10.56 | 11.29 | 12.06 | 12.88 | 13.76 | 14.70 | 15.70 | 16.77 | 17.92 |
| Recombinant Proteins | 6.94 | 7.44 | 7.97 | 8.55 | 9.16 | 9.82 | 10.52 | 11.27 | 12.08 | 12.94 | 13.87 |
| Cell/Gene Therapy | 6.17 | 6.57 | 6.99 | 7.44 | 7.92 | 8.43 | 8.98 | 9.56 | 10.18 | 10.83 | 11.53 |
| Others | 3.86 | 4.07 | 4.29 | 4.52 | 4.77 | 5.03 | 5.30 | 5.59 | 5.89 | 6.21 | 6.54 |
Biopharmaceutical CMO and CRO Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 13.88 | 14.75 | 15.67 | 16.65 | 17.69 | 18.80 | 19.97 | 21.22 | 22.55 | 23.96 | 25.46 |
| Europe | 10.80 | 11.51 | 12.27 | 13.08 | 13.94 | 14.86 | 15.84 | 16.89 | 18.00 | 19.19 | 20.45 |
| Asia Pacific | 11.18 | 11.89 | 12.65 | 13.46 | 14.31 | 15.22 | 16.19 | 17.22 | 18.32 | 19.48 | 20.72 |
| Latin America | 1.54 | 1.64 | 1.74 | 1.84 | 1.96 | 2.08 | 2.21 | 2.34 | 2.48 | 2.64 | 2.80 |
| Middle East & Africa | 1.16 | 1.28 | 1.41 | 1.55 | 1.70 | 1.87 | 2.05 | 2.25 | 2.46 | 2.70 | 2.95 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
